Dostarlimab-gxly
Restricted to use by Oncology in the outpatient setting. Reimbursement and insurance certification or PAP eligibility will be reviewed prior to initiation of therapy.
Reviewed: April 2022 (Jemperli)
Dostarlimab-gxly (Jemperli)
Restricted to use by Oncology in the outpatient setting. Reimbursement and insurance certification or PAP eligibility will be reviewed prior to initiation of therapy.
Reviewed: April 2022 (Jemperli)
Dostarlimab-gxly (Jemperli)